Cardiovascular reactivity of patients with essential and renal hypertension in an emotion-triggering interview

Hans-Christian Deter1, Angela Blecher, Cora S Weber

  • 1Department of Psychosomatic Medicine and Psychotherapy, Charlité Universitätsmedizin, Berlin, Germany. deter@charite.de

Insights

Essential hypertensives show higher cardiovascular activation and slower recovery under mental stress compared to renal hypertensives. This indicates greater sensitivity to stress in essential hypertension.

Area of Science:

  • Cardiology
  • Psychophysiology

Background:

  • Hypertension is associated with heightened blood pressure reactivity to mental stress.
  • Understanding differential cardiovascular responses in hypertensive subgroups is crucial.

Purpose of the Study:

  • To investigate if various stimuli induce distinct cardiovascular responses in essential hypertensives (EHs) versus renal hypertensives (RHs).
  • To compare blood pressure (BP) and heart rate (HR) reactivity between hypertensive subgroups and normotensives (Ns).

Main Methods:

  • 10 EHs, 10 RHs, and 10 Ns were matched for age and gender.
  • Participants underwent an emotion-stimulating interview with continuous BP and HR monitoring.
  • Cardiovascular responses were assessed during different interview phases.

Main Results:

  • Blood pressure reactivity differed between hypertensives (EHs/RHs) and normotensives (Ns) under certain stimuli.
  • No significant differences in BP reactivity were observed between EHs and RHs.
  • A significant difference in the systolic BP and HR product was found between EHs and RHs during the anger/rage phase and baseline 2.

Conclusions:

  • Essential hypertensives exhibit higher cardiovascular activation and impaired recovery compared to renal hypertensives under mental stress.
  • EHs may possess greater sensitivity to perturbations or higher central tension than RHs.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...